By Laura Lutz
Des Moines, Sept. 21 - Microislet, Inc. received $1 million from the private placement of a unsecured convertible promissory note and warrant with existing investor Peter Knobel.
The note bears interest at 10% per year and matures on March 31, 2008. If Microislet raises at least $4.5 million from an equity-based financing before March 31, 2008, the note will mature on the closing date of the financing.
The investor may choose to convert all or a part of the principal and accrued interest into the securities sold in the first equity-based financing that Microislet completes, on the same terms as the rest of the financing.
It may be prepaid at any time without penalty.
Knobel also received a warrant for 400,000 shares at an exercise price of $0.40. The warrant will become exercisable one year after issuance and expire after five years.
MicroIslet is a San Diego-based biotechnology company that develops and commercializes transplant technologies.
Issuer: | Microislet, Inc.
|
Issue: | Convertible promissory note
|
Amount: | $1 million
|
Maturity: | March 31, 2008
|
Coupon: | 10%
|
Price: | Par
|
Yield: | 10%
|
Conversion: | On terms of future equity-based financing
|
Call: | For par plus accrued interest
|
Warrant: | For 400,000 shares
|
Warrant expiration: | Five years
|
Warrant strike price: | $0.40
|
Settlement date: | Sept. 20
|
Stock symbol: | OTCBB: MIIS
|
Stock price: | $0.56 at close Sept. 21
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.